Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
08/04/2021 05:15 PM EDT The final analysis of trial data included 1,098 critically ill and 2,219 moderately ill hospitalized patients who received either a low or full dose of heparin for up to 14 days after enrollment. |
Read about the latest news in Philippines, local news, breaking news, world news, odd news, opinion, and view news photos and videos
Wednesday, August 4, 2021
Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients
Subscribe to:
Post Comments (Atom)
Bitcoin’s 4th Major Profit Cycle is Here...
In every bull market, there are smaller coins that make far more than Bitcoin ...
-
insidecroydon posted: " Become a Patron! What's on inside Croydon: Click here for the latest events listing...
No comments:
Post a Comment